Table of Contents 1 Study Coverage 1.1 Osteoarthritis Pain Drugs Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Product 1.4.2 Oral 1.4.3 Injection 1.4.4 External 1.5 Market by End User 1.5.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by End User 1.5.2 Medical Care 1.5.3 Personal Care 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Osteoarthritis Pain Drugs Market Size 2.1.1 Global Osteoarthritis Pain Drugs Revenue 2014-2025 2.1.2 Global Osteoarthritis Pain Drugs Sales 2014-2025 2.2 Osteoarthritis Pain Drugs Growth Rate by Regions 2.2.1 Global Osteoarthritis Pain Drugs Sales by Regions 2.2.2 Global Osteoarthritis Pain Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Osteoarthritis Pain Drugs Sales by Manufacturers 3.1.1 Osteoarthritis Pain Drugs Sales by Manufacturers 3.1.2 Osteoarthritis Pain Drugs Sales Market Share by Manufacturers 3.1.3 Global Osteoarthritis Pain Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Osteoarthritis Pain Drugs Revenue by Manufacturers 3.2.1 Osteoarthritis Pain Drugs Revenue by Manufacturers (2014-2019) 3.2.2 Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2014-2019) 3.3 Osteoarthritis Pain Drugs Price by Manufacturers 3.4 Osteoarthritis Pain Drugs Manufacturing Base Distribution, Product Types 3.4.1 Osteoarthritis Pain Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Osteoarthritis Pain Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Osteoarthritis Pain Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Osteoarthritis Pain Drugs Sales by Product 4.2 Global Osteoarthritis Pain Drugs Revenue by Product 4.3 Osteoarthritis Pain Drugs Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Osteoarthritis Pain Drugs Breakdown Data by End User 6 North America 6.1 North America Osteoarthritis Pain Drugs by Countries 6.1.1 North America Osteoarthritis Pain Drugs Sales by Countries 6.1.2 North America Osteoarthritis Pain Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Osteoarthritis Pain Drugs by Product 6.3 North America Osteoarthritis Pain Drugs by End User 7 Europe 7.1 Europe Osteoarthritis Pain Drugs by Countries 7.1.1 Europe Osteoarthritis Pain Drugs Sales by Countries 7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Osteoarthritis Pain Drugs by Product 7.3 Europe Osteoarthritis Pain Drugs by End User 8 Asia Pacific 8.1 Asia Pacific Osteoarthritis Pain Drugs by Countries 8.1.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Countries 8.1.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Osteoarthritis Pain Drugs by Product 8.3 Asia Pacific Osteoarthritis Pain Drugs by End User 9 Central & South America 9.1 Central & South America Osteoarthritis Pain Drugs by Countries 9.1.1 Central & South America Osteoarthritis Pain Drugs Sales by Countries 9.1.2 Central & South America Osteoarthritis Pain Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Osteoarthritis Pain Drugs by Product 9.3 Central & South America Osteoarthritis Pain Drugs by End User 10 Middle East and Africa 10.1 Middle East and Africa Osteoarthritis Pain Drugs by Countries 10.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Countries 10.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Osteoarthritis Pain Drugs by Product 10.3 Middle East and Africa Osteoarthritis Pain Drugs by End User 11 Company Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Company Details 11.1.2 Company Business Overview 11.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Johnson & Johnson Osteoarthritis Pain Drugs Products Offered 11.1.5 Johnson & Johnson Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Company Business Overview 11.2.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Pfizer Osteoarthritis Pain Drugs Products Offered 11.2.5 Pfizer Recent Development 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 Company Business Overview 11.3.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.3.4 GlaxoSmithKline Osteoarthritis Pain Drugs Products Offered 11.3.5 GlaxoSmithKline Recent Development 11.4 Mylan 11.4.1 Mylan Company Details 11.4.2 Company Business Overview 11.4.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Mylan Osteoarthritis Pain Drugs Products Offered 11.4.5 Mylan Recent Development 11.5 Lilly 11.5.1 Lilly Company Details 11.5.2 Company Business Overview 11.5.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Lilly Osteoarthritis Pain Drugs Products Offered 11.5.5 Lilly Recent Development 11.6 Sanofi 11.6.1 Sanofi Company Details 11.6.2 Company Business Overview 11.6.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Sanofi Osteoarthritis Pain Drugs Products Offered 11.6.5 Sanofi Recent Development 11.7 Abbott Laboratories 11.7.1 Abbott Laboratories Company Details 11.7.2 Company Business Overview 11.7.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Abbott Laboratories Osteoarthritis Pain Drugs Products Offered 11.7.5 Abbott Laboratories Recent Development 11.8 Bayer 11.8.1 Bayer Company Details 11.8.2 Company Business Overview 11.8.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Bayer Osteoarthritis Pain Drugs Products Offered 11.8.5 Bayer Recent Development 11.9 Almatica Pharma 11.9.1 Almatica Pharma Company Details 11.9.2 Company Business Overview 11.9.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Almatica Pharma Osteoarthritis Pain Drugs Products Offered 11.9.5 Almatica Pharma Recent Development 11.10 TEVA 11.10.1 TEVA Company Details 11.10.2 Company Business Overview 11.10.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue and Gross Margin (2014-2019) 11.10.4 TEVA Osteoarthritis Pain Drugs Products Offered 11.10.5 TEVA Recent Development 11.11 Iroko Pharmaceuticals 12 Future Forecast 12.1 Osteoarthritis Pain Drugs Market Forecast by Regions 12.1.1 Global Osteoarthritis Pain Drugs Sales Forecast by Regions 2019-2025 12.1.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Regions 2019-2025 12.2 Osteoarthritis Pain Drugs Market Forecast by Product 12.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Product 2019-2025 12.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Product 2019-2025 12.3 Osteoarthritis Pain Drugs Market Forecast by End User 12.4 North America Osteoarthritis Pain Drugs Forecast 12.5 Europe Osteoarthritis Pain Drugs Forecast 12.6 Asia Pacific Osteoarthritis Pain Drugs Forecast 12.7 Central & South America Osteoarthritis Pain Drugs Forecast 12.8 Middle East and Africa Osteoarthritis Pain Drugs Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Osteoarthritis Pain Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Osteoarthritis Pain Drugs Product Picture Table Osteoarthritis Pain Drugs Market Segments Table Key Manufacturers Osteoarthritis Pain Drugs Covered Table Global Osteoarthritis Pain Drugs Market Size Growth Rate by Product 2019-2025 (M Dose) & (Million US$) Figure Global Osteoarthritis Pain Drugs Sales Market Share by Product 2014-2025 Figure Oral Product Picture Table Major Manufacturers of Oral Figure Injection Product Picture Table Major Manufacturers of Injection Figure External Product Picture Table Major Manufacturers of External Table Global Osteoarthritis Pain Drugs Market Size Growth Rate by End User 2019-2025 (M Dose) Figure Medical Care Figure Personal Care Figure Osteoarthritis Pain Drugs Report Years Considered Figure Global Osteoarthritis Pain Drugs Market Size 2014-2025 (Million US$) Figure Global Osteoarthritis Pain Drugs Sales 2014-2025 (M Dose) Table Global Osteoarthritis Pain Drugs Market Size by Regions 2014-2019 (M Dose) & (Million US$) Table Global Osteoarthritis Pain Drugs Sales by Regions 2014-2019 (M Dose) Table Global Osteoarthritis Pain Drugs Sales Market Share by Regions 2014-2019 Figure Global Osteoarthritis Pain Drugs Sales Market Share by Regions 2014-2019 Figure 2018 Global Osteoarthritis Pain Drugs Sales Market Share by Regions Table Global Osteoarthritis Pain Drugs Revenue by Regions 2014-2019 (Million US$) Table Global Osteoarthritis Pain Drugs Revenue Market Share by Regions 2014-2019 Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Regions 2014-2019 Figure 2018 Global Osteoarthritis Pain Drugs Revenue Market Share by Regions Table Global Osteoarthritis Pain Drugs Sales by Manufacturers (2014-2019) (M Dose) Table Global Osteoarthritis Pain Drugs Sales Share by Manufacturers (2014-2019) Figure Global Osteoarthritis Pain Drugs Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Osteoarthritis Pain Drugs Revenue by Manufacturers (2014-2019) (Million USD) Table Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2014-2019) Figure Osteoarthritis Pain Drugs Value Share by Manufacturers in 2018 Table Key Manufacturers Osteoarthritis Pain Drugs Price (2014-2019) (USD/K Dose) Table Osteoarthritis Pain Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Osteoarthritis Pain Drugs Product Type Table Date of International Manufacturers Enter into Osteoarthritis Pain Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Osteoarthritis Pain Drugs Sales by Product (2014-2019) (M Dose) Table Global Osteoarthritis Pain Drugs Sales Share by Product (2014-2019) Figure Global Osteoarthritis Pain Drugs Sales Market Share by Product (2014-2019) Figure Global Osteoarthritis Pain Drugs Sales Market Share by Product in 2018 Table Global Osteoarthritis Pain Drugs Revenue by Product (2014-2019) (Million US$) Table Global Osteoarthritis Pain Drugs Revenue Share by Product (2014-2019) Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Product (2014-2019) Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Product in 2018 Table Osteoarthritis Pain Drugs Price by Product 2014-2019 (USD/K Dose) Table Global Osteoarthritis Pain Drugs Sales by End User (2014-2019) (M Dose) Table Global Osteoarthritis Pain Drugs Sales Share by End User (2014-2019) Figure Global Sales Osteoarthritis Pain Drugs Market Share by End User (2014-2019) Figure Global Sales Osteoarthritis Pain Drugs Market Share by End User in 2018 Figure North America Osteoarthritis Pain Drugs Sales Growth Rate 2014-2019 (M Dose) Figure North America Osteoarthritis Pain Drugs Revenue Growth Rate 2014-2019 (Million US$) Table North America Osteoarthritis Pain Drugs Sales by Countries (2014-2019) (M Dose) Table North America Osteoarthritis Pain Drugs Sales Market Share by Countries (2014-2019) Figure 2018 North America Osteoarthritis Pain Drugs Sales Market Share by Countries Table North America Osteoarthritis Pain Drugs Revenue by Countries (2014-2019) (Million US$) Table North America Osteoarthritis Pain Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 North America Osteoarthritis Pain Drugs Revenue Market Share by Countries Figure United States Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure United States Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (M Dose) Figure Canada Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Canada Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Mexico Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Table North America Osteoarthritis Pain Drugs Sales by Product (2014-2019) (M Dose) Table North America Osteoarthritis Pain Drugs Sales Market Share by Product (2014-2019) Figure 2018 North America Osteoarthritis Pain Drugs Market Share by Product Table North America Osteoarthritis Pain Drugs Sales by End User (2014-2019) (M Dose) Table North America Osteoarthritis Pain Drugs Sales Market Share by End User (2014-2019) Figure 2018 North America Osteoarthritis Pain Drugs Market Share by End User Figure Europe Osteoarthritis Pain Drugs Sales Growth Rate 2014-2019 (M Dose) Figure Europe Osteoarthritis Pain Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Europe Osteoarthritis Pain Drugs Sales by Countries (2014-2019) (M Dose) Table Europe Osteoarthritis Pain Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Europe Osteoarthritis Pain Drugs Sales Market Share by Countries Table Europe Osteoarthritis Pain Drugs Revenue by Countries (2014-2019) (Million US$) Table Europe Osteoarthritis Pain Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Osteoarthritis Pain Drugs Revenue Market Share by Countries Figure Germany Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Germany Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure France Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure France Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure UK Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure UK Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Italy Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Russia Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Europe Osteoarthritis Pain Drugs Sales by Product (2014-2019) (M Dose) Table Europe Osteoarthritis Pain Drugs Sales Market Share by Product (2014-2019) Figure 2018 Europe Osteoarthritis Pain Drugs Market Share by Product Table Europe Osteoarthritis Pain Drugs Sales by End User (2014-2019) (M Dose) Table Europe Osteoarthritis Pain Drugs Sales Market Share by End User (2014-2019) Figure 2018 Europe Osteoarthritis Pain Drugs Market Share by End User Figure Asia Pacific Osteoarthritis Pain Drugs Sales Growth Rate 2014-2019 (M Dose) Figure Asia Pacific Osteoarthritis Pain Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Osteoarthritis Pain Drugs Sales by Countries (2014-2019) (M Dose) Table Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Countries Table Asia Pacific Osteoarthritis Pain Drugs Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Countries Figure China Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure China Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Japan Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Korea Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure India Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure India Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Australia Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Indonesia Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Malaysia Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Philippines Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Thailand Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Vietnam Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Singapore Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Osteoarthritis Pain Drugs Sales by Product (2014-2019) (M Dose) Table Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Osteoarthritis Pain Drugs Market Share by Product Table Asia Pacific Osteoarthritis Pain Drugs Sales by End User (2014-2019) (M Dose) Table Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Osteoarthritis Pain Drugs Market Share by End User Figure Central & South America Osteoarthritis Pain Drugs Sales Growth Rate 2014-2019 (M Dose) Figure Central & South America Osteoarthritis Pain Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Osteoarthritis Pain Drugs Sales by Countries (2014-2019) (M Dose) Table Central & South America Osteoarthritis Pain Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Osteoarthritis Pain Drugs Sales Market Share by Countries Table Central & South America Osteoarthritis Pain Drugs Revenue by Countries (2014-2019) (Million US$) Table Central & South America Osteoarthritis Pain Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Osteoarthritis Pain Drugs Revenue Market Share by Countries Figure Brazil Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Brazil Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Argentina Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Osteoarthritis Pain Drugs Sales by Product (2014-2019) (M Dose) Table Central & South America Osteoarthritis Pain Drugs Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Osteoarthritis Pain Drugs Market Share by Product Table Central & South America Osteoarthritis Pain Drugs Sales by End User (2014-2019) (M Dose) Table Central & South America Osteoarthritis Pain Drugs Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Osteoarthritis Pain Drugs Market Share by End User Figure Middle East and Africa Osteoarthritis Pain Drugs Sales Growth Rate 2014-2019 (M Dose) Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Osteoarthritis Pain Drugs Sales by Countries (2014-2019) (M Dose) Table Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Countries Table Middle East and Africa Osteoarthritis Pain Drugs Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Countries Figure GCC Countries Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure GCC Countries Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Turkey Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure Egypt Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Osteoarthritis Pain Drugs Sales Growth Rate (2014-2019) (M Dose) Figure South Africa Osteoarthritis Pain Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Osteoarthritis Pain Drugs Sales by Product (2014-2019) (M Dose) Table Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Osteoarthritis Pain Drugs Market Share by Product Table Middle East and Africa Osteoarthritis Pain Drugs Sales by End User (2014-2019) (M Dose) Table Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Osteoarthritis Pain Drugs Market Share by End User Table Johnson & Johnson Company Details Table Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Johnson & Johnson Recent Development Table Pfizer Company Details Table Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Pfizer Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table GlaxoSmithKline Recent Development Table Mylan Company Details Table Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Mylan Recent Development Table Lilly Company Details Table Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Lilly Recent Development Table Sanofi Company Details Table Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Sanofi Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Abbott Laboratories Recent Development Table Bayer Company Details Table Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Bayer Recent Development Table Almatica Pharma Company Details Table Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table Almatica Pharma Recent Development Table TEVA Company Details Table TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (Million USD), Price (USD/K Dose) and Gross Margin (2014-2019) Table TEVA Recent Development Table Iroko Pharmaceuticals Company Details Table Global Osteoarthritis Pain Drugs Sales Forecast by Regions 2019-2025 (M Dose) Table Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Regions 2019-2025 Table Global Osteoarthritis Pain Drugs Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Regions 2019-2025 Table Global Osteoarthritis Pain Drugs Sales Forecast by Product 2019-2025 (M Dose) Table Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Product 2019-2025 Table Global Osteoarthritis Pain Drugs Revenue Forecast by Product 2019-2025 (Million US$) Table Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Product 2019-2025 Table Global Osteoarthritis Pain Drugs Sales Forecast by End User 2019-2025 (M Dose) Table Global Osteoarthritis Pain Drugs Sales Market Share Forecast by End User 2019-2025 Figure North America Osteoarthritis Pain Drugs Sales Growth Rate Forecast (2019-2025) (M Dose) Figure North America Osteoarthritis Pain Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Osteoarthritis Pain Drugs Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Europe Osteoarthritis Pain Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Osteoarthritis Pain Drugs Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Asia Pacific Osteoarthritis Pain Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Osteoarthritis Pain Drugs Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Central & South America Osteoarthritis Pain Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Osteoarthritis Pain Drugs Sales Growth Rate Forecast (2019-2025) (M Dose) Figure Middle East and Africa Osteoarthritis Pain Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Osteoarthritis Pain Drugs Value Chain Table Osteoarthritis Pain Drugs Customers List Table Osteoarthritis Pain Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Johnson & Johnson Pfizer GlaxoSmithKline Mylan Lilly Sanofi Abbott Laboratories Bayer Almatica Pharma TEVA Iroko Pharmaceuticals